A real-world, point-of-care, randomized, parallel group, open, 6-month clinical study to evaluate the effect of a digital disease management tool in patients with type 2 diabetes mellitus To evaluate the effect of a smart phone- and web portal-based digital disease management tool added to standard care, compared to standard care alone, on glycaemic control in patients with T2DM. Principal investigators: Dr Calum MacKenzie and Dr Simon Barrett Number and location of participating sites (by region/ country): UK 20 sites Funder: Parexel Start and End date of grant award: 05/2016 to 11/2016 Current Status: Awaiting publication Contact details / Sponsor: AstraZeneca Dr. Manish Saxena, William Harvey Heart Centre, Barts and The London School of Medicine & Dentistry, Charterhouse Square, London ECIM 6BQ Trial Management: Morag MacLean Clinical Team: Guen Innes/Susan Begg ECTU involvement: Trial Management, Clinical support – research nurses This article was published on 2024-09-24
